Skip To Main Content
Hathaichanok Sumalee on Muck Rack

Hathaichanok Sumalee

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Hathaichanok

Contact Hathaichanok, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Economic evaluation of SGLT2 inhibitors and GLP-1 receptor agonists in Thai patients with type 2 diabetes and established atherosclerotic cardiovascular disease

|
By Tanawan Kongmalai, Natthakan Chitpim, Varalak Srinonprasert, Pattara Leelahavarong, Hathaichanok Sumalee
| Nature Verified
Abstract Type 2 diabetes (T2D) with established atherosclerotic cardiovascular disease (ASCVD) imposes a substantial clinical and economic burden in Thailand. Although sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown cardiovascular benefits, they are not currently included in Thailand’s National List of Essential Medicines (NLEM).
Open in Who Shared Issue with article?
See all 1 articles